SCHEMBL27628252

SCHEMBL27628252

CC(c1cccc(C(=O)O)c1)N1CCCCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.56
SLC6A2 P23975 6/20 0.50
CHRNB4 P30926 6/20 0.50
CHRNA3 P32297 6/20 0.50
SLC6A3 Q01959 6/20 0.50
CHRNB2 P17787 5/20 0.50
CHRNA4 P43681 5/20 0.50
CHRNA1 P02708 4/20 0.50
CHRNG P07510 4/20 0.50
CHRNB1 P11230 4/20 0.50
CHRND Q07001 4/20 0.50
HPGD P15428 2/20 0.50
GAA P10253 2/20 0.50
KDM4E B2RXH2 1/20 0.50
MEN1 O00255 1/20 0.50
ALDH1A1 P00352 1/20 0.50
KMT2A Q03164 1/20 0.50
HSD17B10 Q99714 1/20 0.50
SLC6A4 P31645 1/20 0.49
CYP2C9 P11712 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17911066 0.87 CYP2D6 (0.46) ACHEHPGDGAAKDM4EMEN1
SCHEMBL26144986 0.84 OPRM1 (0.47) ACHEHPGDGAAKDM4EMEN1
SCHEMBL608660 0.82 ACHE (0.50) ACHESLC6A2CHRNB4CHRNA3SLC6A3
SCHEMBL11189977 0.78 ACHE (0.55) ACHEALDH1A1CYP2C9CYP2D6CYP1A2
SCHEMBL11191579 0.78 ACHE (0.55) ACHEALDH1A1CYP2C9CYP2D6CYP1A2
SCHEMBL8498919 0.77 KMT2A (0.61) HPGDGAAKDM4EMEN1ALDH1A1
SCHEMBL2631769 0.76 CYP2D6 (0.79) GAAMEN1ALDH1A1KMT2ACYP2C9
SCHEMBL20191913 0.76 CYP2D6 (0.79) GAAMEN1ALDH1A1KMT2ACYP2C9
SCHEMBL1406105 0.76 CYP2D6 (0.79) GAAMEN1ALDH1A1KMT2ACYP2C9
SCHEMBL11180959 0.76 ACHE (0.52) ACHESLC6A3ALDH1A1SLC6A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1738805-A N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as CGRP-antagonists for treating a headache BOEHRINGER INGELHEIM INT (DE) 2006-02-22 CN disclosed